Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice

Human Molecular Genetics

Volumn 19, Issue 22, 2010, Pages 4515-4528

  Brown, Jacquelyn A ^a   Emnett, Ryan J ^a   White, Crystal R ^a   Yuede, Carla M ^a   Conyers, Sara B ^a   O'Malley, Karen L ^a   Wozniak, David F ^a   Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; DOPAMINE; LEVODOPA; METHYLPHENIDATE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DISTURBANCE; BEHAVIOR DISORDER; CATECHOLAMINE BRAIN LEVEL; CELL LOSS; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; GENE; HOMEOSTASIS; HYPERACTIVITY; IN VITRO STUDY; LEARNING DISORDER; MOUSE; NERVE CELL GROWTH; NERVE PROJECTION; NEURITE; NEUROFIBROMATOSIS; NF1 GENE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REARING; SELECTIVE ATTENTION; STIMULUS RESPONSE; SUBSTANTIA NIGRA;

ANIMALS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CHILD; CORPUS STRIATUM; DOPAMINE; GENES, NEUROFIBROMATOSIS 1; HUMANS; LEVODOPA; METHYLPHENIDATE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MOTOR ACTIVITY; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; NEURONS; OPTIC NERVE GLIOMA; SUBSTANTIA NIGRA;

MUS;

EID: 77958498935     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq382     Document Type: Article

References (44)

1. Coude, F.X., Mignot, C., Lyonnet, S. and Munnich, A. (2006) Academic impairment is the most frequent complication of neurofibromatosis type-1 (NF1) in children. Behav. Genet., 36, 660-664.
2. Descheemaeker, M.J., Ghesquiere, P., Symons, H., Fryns, J.P. and Legius, E. (2005) Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children. J. Intellect. Disabil. Res., 49, 33-46.
3. Dilts, C.V., Carey, J.C., Kircher, J.C., Hoffman, R.O., Creel, D., Ward, K., Clark, E. and Leonard, C.O. (1996) Children and adolescents with neurofibromatosis 1: a behavioral phenotype. J. Dev. Behav. Pediatr., 17, 229-239.
4. Hyman, S.L., Shores, A. and North, K.N. (2005) The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology, 65, 1037-1044.
5. North, K.N., Riccardi, V., Samango-Sprouse, C., Ferner, R., Moore, B., Legius, E., Ratner, N. and Denckla, M.B. (1997) Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force. Neurology, 48, 1121-1127.
6. Reimers, T.S., Ehrenfels, S., Mortensen, E.L., Schmiegelow, M., Sonderkaer, S., Carstensen, H., Schmiegelow, K. and Muller, J. (2003) Cognitive deficits in long-term survivors of childhood brain tumors: identification of predictive factors. Med. Pediatr. Oncol., 40, 26-34.
7. Rosser, T.L. and Packer, R.J. (2003) Neurocognitive dysfunction in children with neurofibromatosis type 1. Curr. Neurol. Neurosci. Rep., 3, 129-136.
8. Schrimsher, G.W., Billingsley, R.L., Slopis, J.M. and Moore, B.D. 3rd (2003) Visual-spatial performance deficits in children with neurofibromatosis type-1. Am. J. Med. Genet. A., 120A, 326-330.
9. Barton, B. and North, K. (2004) Social skills of children with neurofibromatosis type 1. Dev. Med. Child. Neurol., 46, 553-563.
10. Maddrey, A.M., Bergeron, J.A., Lombardo, E.R., McDonald, N.K., Mulne, A.F., Barenberg, P.D. and Bowers, D.C. (2005) Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J. Neurooncol., 72, 245-253.
11. Hyman, S.L., Arthur Shores, E. and North, K.N. (2006) Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Dev. Med. Child. Neurol., 48, 973-977.
12. Mautner, V.F., Kluwe, L., Thakker, S.D. and Leark, R.A. (2002) Treatment of ADHD in neurofibromatosis type 1. Dev. Med. Child. Neurol., 44, 164-170.
13. Silva, A.J., Frankland, P.W., Marowitz, Z., Friedman, E., Laszlo, G.S., Cioffi, D., Jacks, T. and Bourtchuladze, R. (1997) A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat. Genet., 15, 281-284.
14. Aspide, R., Fresiello, A., de Filippis, G., Gironi Carnevale, U.A. and Sadile, A.G. (2000) Non-selective attention in a rat model of hyperactivity and attention deficit: subchronic methylphenydate and nitric oxide synthesis inhibitor treatment. Neurosci. Biobehav. Rev., 24, 59-71.
15. Vallone, D., Pignatelli, M., Grammatikopoulos, G., Ruocco, L., Bozzi, Y., Westphal, H., Borrelli, E. and Sadile, A.G. (2002) Activity, non-selective attention and emotionality in dopamine D2/D3 receptor knock-out mice. Behav. Brain Res., 130, 141-148.
16. Li, W., Cui, Y., Kushner, S.A., Brown, R.A., Jentsch, J.D., Frankland, P.W., Cannon, T.D. and Silva, A.J. (2005) The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr. Biol., 15, 1961-1967.
17. Yuede, C.M., Zimmerman, S.D., Dong, H., Kling, M.J., Bero, A.W., Holtzman, D.M., Timson, B.F. and Csernansky, J.G. (2009) Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease. Neurobiol. Dis., 35, 426-432.
18. Borycz, J., Zapata, A., Quiroz, C., Volkow, N.D. and Ferre, S. (2008) 5-HT 1B receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats. Neuropsychopharmacology, 33, 619-626.
19. Jaber, M., Bloch, B., Caron, M.G. and Giros, B. (1998) Behavioral, cellular and molecular consequences of the dopamine transporter gene inactivation. C R. Seances Soc. Biol. Fil., 192, 1127-1137.
20. Oades, R.D. (2008) Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD). Prog. Brain. Res., 172, 543-565.
21. Georgievska, B., Kirik, D. and Bjorklund, A. (2002) Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp. Neurol., 177, 461-474.
22. Stephenson, D., Ramirez, A., Long, J., Barrezueta, N., Hajos-Korcsok, E., Matherne, C., Gallagher, D., Ryan, A., Ochoa, R., Menniti, F. et al. (2007) Quantification of MPTP-induced dopaminergic neurodegeneration in the mouse substantia nigra by laser capture microdissection. J. Neurosci. Methods., 159, 291-299.
23. Madisen, L., Zwingman, T.A., Sunkin, S.M., Oh, S.W., Zariwala, H.A., Gu, H., Ng, L.L., Palmiter, R.D., Hawrylycz, M.J., Jones, A.R. et al. (2010) A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci., 13, 133-140.
24. Brown, J.A., Gianino, S.M. and Gutmann, D.H. (2010) Defective cyclic AMP generation underlies the sensitivity of central nervous system neurons to neurofibromatosis-1 heterozygosity. J. Neurosci., 30, 5579-5589.
25. Eldridge, R., Denckla, M.B., Bien, E., Myers, S., Kaiser-Kupfer, M.I., Pikus, A., Schlesinger, S.L., Parry, D.M., Dambrosia, J.M., Zasloff, M.A. et al. (1989) Neurofibromatosis type 1 (Recklinghausen's disease). Neurologic and cognitive assessment with sibling controls. Am. J. Dis. Child., 143, 833-837.
26. Banerjee, D., Hegedus, B., Gutmann, D.H. and Garbow, J.R. (2007) Detection and measurement of neurofibromatosis-1 mouse optic glioma in vivo. Neuroimage, 35, 1434-1437.
27. Hegedus, B., Banerjee, D., Yeh, T.H., Rothermich, S., Perry, A., Rubin, J.B., Garbow, J.R. and Gutmann, D.H. (2008) Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma. Cancer Res., 68, 1520-1528.
28. Markowitz, J.S., DeVane, C.L., Pestreich, L.K., Patrick, K.S. and Muniz, R. (2006) A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study. J. Child. Adolesc. Psychopharmacol., 16, 687-698.
29. Wilens, T.E. (2008) Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J. Clin. Psychopharmacol., 28, 46-53.
30. Glavan, G. and Zivin, M. (2005) Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats. Neuroscience, 135, 545-554.
31. Wong, D.L. and Tank, A.W. (2007) Stress-induced catecholaminergic function: transcriptional and post-transcriptional control. Stress, 10, 121-130.
32. Hegedus, B., Dasgupta, B., Shin, J.E., Emnett, R.J., Hart-Mahon, E.K., Elghazi, L., Bernal-Mizrachi, E. and Gutmann, D.H. (2007) Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP-and Ras-dependent mechanisms. Cell Stem Cell, 1, 443-457.
33. Garthe, A., Behr, J. and Kempermann, G. (2009) Adult-generated hippocampal neurons allow the flexible use of spatially precise learning strategies. PLoS ONE, 4, e5464.
34. Lagace, D.C., Donovan, M.H., DeCarolis, N.A., Farnbauch, L.A., Malhotra, S., Berton, O., Nestler, E.J., Krishnan, V. and Eisch, A.J. (2010) Adult hippocampal neurogenesis is functionally important for stress-induced social avoidance. Proc. Natl Acad. Sci. USA, 107, 4436-4441.
35. Zhao, M., Momma, S., Delfani, K., Carlen, M., Cassidy, R.M., Johansson, C.B., Brismar, H., Shupliakov, O., Frisen, J. and Janson, A.M. (2003) Evidence for neurogenesis in the adult mammalian substantia nigra. Proc. Natl Acad. Sci. USA, 100, 7925-7930.
36. Bajenaru, M.L., Hernandez, M.R., Perry, A., Zhu, Y., Parada, L.F., Garbow, J.R. and Gutmann, D.H. (2003) Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res., 63, 8573-8577.
37. Bajenaru, M.L., Zhu, Y., Hedrick, N.M., Donahoe, J., Parada, L.F. and Gutmann, D.H. (2002) Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol. Cell. Biol., 22, 5100-5113.
38. Brannan, C.I., Perkins, A.S., Vogel, K.S., Ratner, N., Nordlund, M.L., Reid, S.W., Buchberg, A.M., Jenkins, N.A., Parada, L.F. and Copeland, N.G. (1994) Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev., 8, 1019-1029.
39. Wozniak, D.F., Hartman, R.E., Boyle, M.P., Vogt, S.K., Brooks, A.R., Tenkova, T., Young, C., Olney, J.W. and Muglia, L.J. (2004) Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning/memory deficits in juveniles followed by progressive functional recovery in adults. Neurobiol. Dis., 17, 403-414.
40. Dere, E., Huston, J.P. and De Souza Silva, M.A. (2005) Episodic-like memory in mice: simultaneous assessment of object, place and temporal order memory. Brain Res. Protoc., 16, 10-19.
41. Grady, R.M., Wozniak, D.F., Ohlemiller, K.K. and Sanes, J.R. (2006) Cerebellar synaptic defects and abnormal motor behavior in mice lacking alpha-and beta-dystrobrevin. J. Neurosci., 26, 2841-2851.
42. Prusky, G.T., Alam, N.M., Beekman, S. and Douglas, R.M. (2004) Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest. Ophthalmol. Vis. Sci., 45, 4611-4616.
43. Zhou, Q.Y. and Palmiter, R.D. (1995) Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell, 83, 1197-1209.
44. Wang, P., Niu, L., Guo, X.D., Gao, L., Li, W.X., Jia, D., Wang, X.L., Ma, L.T. and Gao, G.D. (2010) Gypenosides protects dopaminergic neurons in primary culture against MPP(+)-induced oxidative injury. Brain. Res. Bull. [Epub ahead of print].